User profiles for Nicholas Meti
 | Nicholas Meti, MDMcGill University Verified email at mcgill.ca Cited by 434 |
[HTML][HTML] A review and comparison of breast tumor cell nuclei segmentation performances using deep convolutional neural networks
Breast cancer is currently the second most common cause of cancer-related death in women.
Presently, the clinical benchmark in cancer diagnosis is tissue biopsy examination. …
Presently, the clinical benchmark in cancer diagnosis is tissue biopsy examination. …
Computational radiology in breast cancer screening and diagnosis using artificial intelligence
Breast cancer screening has been shown to significantly reduce mortality in women. The
increased utilization of screening examinations has led to growing demands for rapid and …
increased utilization of screening examinations has led to growing demands for rapid and …
[HTML][HTML] Adverse events associated with immune checkpoint inhibitor treatment for cancer
We searched PubMed from 2010 to 2018 for articles about immunerelated adverse events
and immune checkpoint inhibitors and selected randomized controlled trials, systematic …
and immune checkpoint inhibitors and selected randomized controlled trials, systematic …
[HTML][HTML] Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern
Claudin-2 promotes breast cancer liver metastasis by enabling seeding and early cancer cell
survival. We now demonstrate that Claudin-2 is functionally required for colorectal cancer …
survival. We now demonstrate that Claudin-2 is functionally required for colorectal cancer …
Cancer treatment during COVID-19: a qualitative analysis of patient-perceived risks and experiences with virtual care
L Gotlib Conn, H Tahmasebi, N Meti… - Journal of Patient …, 2021 - journals.sagepub.com
During the COVID-19 pandemic, most cancer centers shifted from in-person to virtual cancer
care to curb community spread and ensure care continuity. This qualitative descriptive study …
care to curb community spread and ensure care continuity. This qualitative descriptive study …
Machine learning frameworks to predict neoadjuvant chemotherapy response in breast cancer using clinical and pathological features
PURPOSE Neoadjuvant chemotherapy (NAC) is used to treat locally advanced breast cancer
(LABC) and high-risk early breast cancer (BC). Pathological complete response (pCR) has …
(LABC) and high-risk early breast cancer (BC). Pathological complete response (pCR) has …
[HTML][HTML] The role of immune checkpoint inhibitors in classical Hodgkin lymphoma
Hodgkin Lymphoma (HL) is a unique disease entity both in its pathology and the young
patient population that it primarily affects. Although cure rates are high, survivorship can be …
patient population that it primarily affects. Although cure rates are high, survivorship can be …
Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis
Purpose The addition of platinum agents to anthracycline and taxane-based chemotherapy
in early-stage triple negative breast cancer (TNBC) patients improves pathological complete …
in early-stage triple negative breast cancer (TNBC) patients improves pathological complete …
[HTML][HTML] Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly …
Background The role for radiotherapy or surgery in the upfront management of brain
metastases (BrM) in epidermal growth factor receptor mutant (EGFRm) or anaplastic lymphoma …
metastases (BrM) in epidermal growth factor receptor mutant (EGFRm) or anaplastic lymphoma …
[PDF][PDF] Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction
Small-cell lung cancer (SCLC) methylome is understudied. Here, we comprehensively
profile SCLC using cell-free methylated DNA immunoprecipitation followed by sequencing (…
profile SCLC using cell-free methylated DNA immunoprecipitation followed by sequencing (…